CORIELL INSTITUTE FOR MEDICAL RESEARCH, INC.

Coriell Institute for Medical Research, Inc. specializes in the selection, production, characterization, and distribution of cultured human cells and DNA resources for biomedical research, with a focused emphasis on aging and neurological disorders. Their technical expertise lies in cell line development, genetic repository management, and high-fidelity biological sample characterization, supporting foundational research in genetics, epigenetics, and cellular aging. The institute operates as a critical infrastructure provider for the life sciences community, offering standardized, ethically sourced, and rigorously validated biological materials that enable reproducible research across academic, clinical, and pharmaceutical settings. Their unique capability centers on long-term biobanking, quality control of primary cell cultures, and distribution systems that ensure sample integrity for global research use. The organization maintains a consistent relationship with the Department of Health and Human Services, delivering specialized research resources under programs managed by the National Institutes of Health, particularly the National Institute of Neurological Disorders and Stroke. Their work supports NIH-funded investigations into neurodegenerative diseases and age-related biological mechanisms through the provision of well-documented cell lines and genomic materials. Their primary industry focus is in research and development within the life sciences, specifically in the non-biotechnology domain of human biological resource generation and distribution. This positions them as a niche provider of essential tools for basic and translational research, distinct from commercial biotech firms that focus on therapeutics or diagnostics. Coriell Institute for Medical Research, Inc. is a non-profit research entity headquartered in Camden, New Jersey, with no federal business certifications on record. Their government market presence is defined by sustained, mission-driven collaborations with federal health research agencies, leveraging scientific rigor and operational reliability to serve the public health research ecosystem.